Clinical Trial Update: Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder

View source ↗

Summary

AstraZeneca-sponsored clinical trial evaluating sub-syndromal symptoms after an acute depressive episode in bipolar disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder, Sub-syndromal Symptoms | Status: TERMINATED